Sobi Expands Hematology Portfolio with $1.7B Buy of CTI 5/10/2023

FDA Approves Fabry Disease Treatment from Chiesi, Protalix 5/10/2023

Amgen Drops Drug Delivery Partnership, Targets Crohn’s Disease with TScan Pact 5/10/2023

Roche Cuts 165 Jobs in New Jersey, Scales Back COVID-19 Portfolio 5/10/2023

Pharma’s Biggest Losses: Once-Dropped Drugs Make Lucrative Comebacks 5/10/2023

In Another Round of Cuts, Biogen Lays Off Unspecified Number of Employees 4/10/2023

AbbVie, J&J Pull Two Accelerated Approvals for Imbruvica 4/10/2023

Gene Editing Therapeutics Could Hit the Market in 2023 4/10/2023

FDA Action Alert: Alvotech, Otsuka and More 4/10/2023

Pfizer’s Biohaven Bet Pays Off Again as Migraine Nasal Spray Wins Approval 3/10/2023

Clinical Hold on Fulcrum's Sickle Cell Hopeful Triggered by Hematologic Malignancies Profile 3/10/2023

Independent Panel Recommends Polivy in First Line LBCL Despite FDA Reservations 3/10/2023

Novavax Cuts 25% of Staff Amid Post-Pandemic Business Challenges 5/9/2023

EQRx Cuts More Than Half of Headcount in Strategic Reset 5/9/2023

Eisai Pays up to $2B for ADC Bearing Its Halaven as Payload 5/9/2023

Catalent Delays Earnings Call, Shaves $400M Off FY23 Guidance 5/9/2023

A Guide to Becoming a Clinical Laboratory Technician 5/9/2023

Clene's Nanocrystal ALS Treatment Bounces Back with Positive Data 3/9/2023

Bayer Plans to Double Down on US Pharma R&D in 2023 3/9/2023

AstraZeneca Notches Back-to-Back Late-Stage Wins in Lung Cancer 3/9/2023